Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
S
Sonu Pahal
Researcher
Also affiliated: Indian Institute of Information Technology Allahabad (2021–2022); Institute on Aging (2024–2025); Indian Institute of Technology Indore (2021)
Faculty Researcher
6 h-index
15 pubs
116 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sonu Pahal's research investigates neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, with a focus on identifying potential therapeutic targets and drug candidates. This work involves computational biology and molecular docking simulations to evaluate natural compounds, such as those found in *Withania somnifera*, for their inhibitory effects against disease-related targets. Pahal also explores the role of mitochondria in aging and age-associated diseases and examines the potential of compounds like ezetimibe to mitigate Alzheimer's risk by targeting specific molecular interactions. The research network includes collaborators from the University of Arkansas for Medical Sciences, such as Meenakshisundaram Balasubramaniam and Srinivas Ayyadevara. Pahal has authored 15 publications, with an h-index of 6 and 97 citations.
Metrics
- h-index: 6
- Publications: 15
- Citations: 116
Selected Publications
-
Brain peptides in Alzheimer’s disease - pathophysiology and therapeutic advances (2026)
-
The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease (2026)
-
Role of Monoclonal Antibodies in Alzheimer’s Disease: Successes, Failures, and Future Directions (2025)
-
Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology (2025)
-
Mitochondria in aging and age-associated diseases (2025)
-
From data to discovery: Neuroinformatics in understanding Alzheimer's disease (2024)
-
Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)
-
Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets (2023)
Collaboration Network
Top Collaborators
Srinivas Ayyadevara
University of Arkansas at Little Rock
4 shared publications
In database
- Mitochondria in aging and age-associated diseases
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology
- The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease
Meenakshisundaram Balasubramaniam
University of Arkansas for Medical Sciences
4 shared publications
In database
- Mitochondria in aging and age-associated diseases
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology
- The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease
Robert J. Shmookler Reis
Institute on Aging
3 shared publications
In database
- Mitochondria in aging and age-associated diseases
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology
Nirjal Mainali
University of Arkansas at Little Rock
3 shared publications
In database
- Mitochondria in aging and age-associated diseases
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology
Amit Chaudhary
University of Alabama at Birmingham (US)
3 shared publications
- From data to discovery: Neuroinformatics in understanding Alzheimer's disease
- Role of Monoclonal Antibodies in Alzheimer’s Disease: Successes, Failures, and Future Directions
- Brain peptides in Alzheimer’s disease - pathophysiology and therapeutic advances
Akshatha Ganne
University of Arkansas for Medical Sciences
2 shared publications
In database
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease
Vishvender Pahal
National Institute of Pharmaceutical Education and Research (IN)
2 shared publications
- From data to discovery: Neuroinformatics in understanding Alzheimer's disease
- Brain peptides in Alzheimer’s disease - pathophysiology and therapeutic advances
Arushi Gupta
Amity University (IN)
2 shared publications
- Role of Monoclonal Antibodies in Alzheimer’s Disease: Successes, Failures, and Future Directions
- Brain peptides in Alzheimer’s disease - pathophysiology and therapeutic advances
Ramani Atluri
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
Joseph Asante
University of Arkansas at Little Rock
1 shared publication
In database
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
Corey Nagel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
Srikanth Vallurupalli
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
W. Sue T. Griffin
Institute on Aging
1 shared publication
In database
- Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology
Vivek Kumar
University of South Florida (US)
1 shared publication
- Role of Monoclonal Antibodies in Alzheimer’s Disease: Successes, Failures, and Future Directions
Sue Griffin
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease
Similar Researchers
Based on overlapping research topics
Khaled Dostzada
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Neuroscience and Neuropharmacology Research
Dementia and Cognitive Impairment Research
Nouf Masarweh
University of Arkansas at Little Rock
Neurological disorders and treatments
Computational Drug Discovery Methods
Advanced Neural Network Applications
Shitiz Sriwastava
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Dementia and Cognitive Impairment Research
Neuroinflammation and Neurodegeneration Mechanisms
Stephen Brasseux
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Neuroscience and Neuropharmacology Research
Dementia and Cognitive Impairment Research
Rohit Dhall
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Neuroscience and Neuropharmacology Research
Dementia and Cognitive Impairment Research
Praveen Kumar Ramani
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Neuroinflammation and Neurodegeneration Mechanisms
Advanced Neural Network Applications